Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
At Hospital/Institution:  University of Virginia Cancer Center
Results 1-25 of 4236 for your search:
Start Over
Surgery Alone, Surgery With Cyclophosphamide, Vinblastine, and Prednisolone (CVP), or CVP Alone in Treating Young Patients With Stage IA or Stage IIA Nodular Lymphocyte-Predominant Hodgkin Lymphoma
Phase: Phase IV
Type: Treatment
Age: 17 and under
Trial IDs: CDR0000667369, NCI-2014-02026, EU-21011, EUDRACT-2007-004092-19, EURONET-PHL-LP1, NCT01088750
Comparison Of 2 Doses Of Temsirolimus (Torisel) In Patients With Mantle Cell Lymphoma
Phase: Phase IV
Type: Treatment
Age: 18 and over
Trial IDs: 3066K1-4438, NCI-2014-00131, 2009-015498-11, B1771007, NCT01180049
Interpersonal Therapy for Depression in Breast Cancer
Phase: Phase IV
Type: Behavioral study, Supportive care
Age: 18 to 90
Trial IDs: #5996/7033R, NCI-2014-02374, #5996, NCT01191580
Transurethral Resection of Bladder Tumors Using PK Button Vaporization Electrode or Monopolar Loop Electrocautery in Treating Patients with Bladder Cancer
Phase: Phase IV
Type: Treatment
Age: 18 to 89
Trial IDs: WCI2119-11, NCI-2013-00065, IRB00053735, NCT01567462
Safety and Efficacy Study of the Xoft® Axxent® eBx™ IORT System
Phase: Phase IV
Type: Treatment
Age: 40 and over
Trial IDs: CTPR-0009, NCI-2013-01601, NCT01644669
An Extension (Rollover) Study of Vemurafenib in Patients With BRAF V600 Mutation-Positive Malignancies Previously Enrolled in an Antecedent Vemurafenib Protocol
Phase: Phase IV
Type: Treatment
Age: 18 and over
Trial IDs: GO28399, NCI-2013-01160, 2012-003144-80, NCT01739764
Post-approval Study of NovoTTF-100A in Recurrent GBM Patients
Phase: Phase IV
Type: Biomarker/Laboratory analysis, Treatment
Age: 22 and over
Trial IDs: EF-19, NCI-2013-00553, NCT01756729
Everolimus Roll-over Protocol for Patients Who Have Completed a Previous Novartis-sponsored Everolimus Study.
Phase: Phase IV
Type: Treatment
Age: Not specifiec
Trial IDs: CRAD001C2X01B, NCI-2013-01151, NCT01789281
Sorafenib Tosylate in Treating Patients with Advanced Liver Cancer and Hepatitis C Infection
Phase: Phase IV
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: 12-213, NCI-2013-01103, NCT01849588
A Study to Evaluate the Potential Increased Risk of Seizures Among Metastatic Castration-Resistant Prostate Cancer (mCRPC) Patients Treated With Enzalutamide
Phase: Phase IV
Type: Supportive care
Age: Not specified
Trial IDs: 9785-CL-0403, NCI-2014-01193, 2013-003022-92, U1111-1157-0224, NCT01977651
Efficacy Evaluation of Dotarem®-Enhanced MRI Compared to Gadovist®/Gadavist®-Enhanced MRI in the Diagnosis of Brain Tumors
Phase: Phase IV
Type: Diagnostic
Age: 18 and over
Trial IDs: DGD-44-058, NCI-2015-00294, NCT02034708
Safety and Efficacy Study of Abraxane in Combination With Carboplatin to Treat Advanced NSCL Cancer in the Elderly
Phase: Phase IV
Type: Treatment
Age: 70 and over
Trial IDs: ABI-007-NSCL-005, NCI-2014-02488, NCT02151149
NeoMend ProGEL™ Pleural Air Leak Sealant Post-Approval Study
Phase: Phase IV
Type: Supportive care
Age: 18 and over
Trial IDs: NEO09-100, NCI-2012-02974, NCT01394978
Varenicline and Nicotine Replacement Therapy for Initial Smoking Cessation and Treatment in Smokers
Phase: Phase IV
Type: Behavioral study, Prevention
Age: 18 to 65
Trial IDs: 2014-0213, NCI-2015-00610, NCT02271919
Perampanel in Lowering the Incidence of Seizures in Patients with Primary Glioma
Phase: Phase IV
Type: Supportive care
Age: 18 and over
Trial IDs: Pro00055609, NCI-2015-00365, NCT02363933
Vismodegib in Treating Patients with Orbital or Periocular Basal Cell Carcinoma
Phase: Phase IV
Type: Treatment
Age: 18 and over
Trial IDs: UMCC 2014.022, NCI-2015-00927, ML29160, NCT02436408
Study Evaluating The Safety Of Subcutaneous Methylnaltrexone In Treatment Of Opioid-Induced Constipation
Phase: Phase IV
Type: Treatment
Age: 18 and over
Trial IDs: 3200K1-4001, NCI-2010-01965, B2541006, NCT00672139
Study to Allow Access to Nilotinib for Patients Who Are on Nilotinib Treatment in a Novartis-sponsored Study
Phase: Phase IV
Type: Treatment
Age: Not specified
Trial IDs: CAMN107A2409, NCI-2013-02332, 2012-003902-28, NCT01735955
Efficacy and Safety of Ferriprox® in Patients With Sickle Cell Disease or Other Anemias
Phase: Phase IV
Type: Treatment
Age: 2 and over
Trial IDs: LA38-0411, NCI-2014-01229, NCT02041299
Regadenoson Stress Echocardiogram in Detecting Coronary Artery Disease in Patients with Cancer
Phase: Phase IV
Type: Diagnostic
Age: 18 to 80
Trial IDs: 2013-0881, NCI-2014-01162, NCT02130453
Early Access Treatment With Daratumumab for (Relapsed or Refractory) Multiple Myeloma
Phase: Phase IV
Type: Treatment
Age: 18 and over
Trial IDs: CR106626, NCI-2015-01138, 54767414MMY3010, NCT02477891
Autologous Peripheral Blood Stem Cell Transplant in Treating Patients With Lymphoma
Phase: Phase III, Phase II
Type: Treatment
Age: Under 70
Trial IDs: MT 2004-24, NCI-2010-01414, 2005LS048, UMN-2005LS048, UMN-0508M72589, UMN-MT2004-24, NCT00345865
Start Over